Literature DB >> 14960328

Endogenous calmodulin interacts with the epidermal growth factor receptor in living cells.

Hongbing Li1, María José Ruano, Antonio Villalobo.   

Abstract

We have previously shown that exogenous calmodulin (CaM) binds to the epidermal growth factor receptor (EGFR) at its cytosolic juxtamembrane region inhibiting its tyrosine kinase activity. We demonstrate in this report that endogenous CaM binds to EGFR in intact cells as CaM co-immunoprecipitates with EGF-activated and non-activated receptors. We also show in living cells that cell-permeable CaM inhibitors prevent the full transphosphorylation of wild type EGFR but not the transphosphorylation of an insertional EGFR mutant in which the CaM-binding domain was divided into two parts. Overall these results suggest that CaM interacts with EGFR in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14960328     DOI: 10.1016/S0014-5793(04)00067-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.

Authors:  Stuart McLaughlin; Steven O Smith; Michael J Hayman; Diana Murray
Journal:  J Gen Physiol       Date:  2005-06-13       Impact factor: 4.086

2.  Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin.

Authors:  Hongbing Li; Svetlana Panina; Amandeep Kaur; María J Ruano; Pablo Sánchez-González; Jonas M la Cour; Alexander Stephan; Uffe H Olesen; Martin W Berchtold; Antonio Villalobo
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

3.  KCNE4 juxtamembrane region is required for interaction with calmodulin and for functional suppression of KCNQ1.

Authors:  Erin J Ciampa; Richard C Welch; Carlos G Vanoye; Alfred L George
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

4.  CaM interaction and Ser181 phosphorylation as new K-Ras signaling modulators.

Authors:  Blanca Alvarez-Moya; Carles Barceló; Francesc Tebar; Montserrat Jaumot; Neus Agell
Journal:  Small GTPases       Date:  2011-03

5.  The ErbB2/Neu/HER2 receptor is a new calmodulin-binding protein.

Authors:  Hongbing Li; Juan Sánchez-Torres; Alan Del Carpio; Valentina Salas; Antonio Villalobo
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

6.  Protein kinaseCdelta-calmodulin crosstalk regulates epidermal growth factor receptor exit from early endosomes.

Authors:  Anna Lladó; Francesc Tebar; Maria Calvo; Jemina Moretó; Alexander Sorkin; Carlos Enrich
Journal:  Mol Biol Cell       Date:  2004-09-01       Impact factor: 4.138

7.  Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression.

Authors:  Matthew R Hart; Hsin-Yuan Su; Derrick Broka; Aarthi Goverdhan; Joyce A Schroeder
Journal:  Mol Ther       Date:  2013-10-01       Impact factor: 11.454

8.  Palmitoylation of the EGF receptor impairs signal transduction and abolishes high-affinity ligand binding.

Authors:  Jennifer L Macdonald-Obermann; Linda J Pike
Journal:  Biochemistry       Date:  2009-03-24       Impact factor: 3.162

Review 9.  HER2 therapy. HER2 (ERBB2): functional diversity from structurally conserved building blocks.

Authors:  Ralf Landgraf
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

10.  Ca2+/Calmodulin and Apo-Calmodulin Both Bind to and Enhance the Tyrosine Kinase Activity of c-Src.

Authors:  Silviya R Stateva; Valentina Salas; Estefanía Anguita; Gustavo Benaim; Antonio Villalobo
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.